BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of 1.70 billion. The enterprise value is 1.63 billion.
| Market Cap | 1.70B |
| Enterprise Value | 1.63B |
Important Dates
The next estimated earnings date is Wednesday, May 21, 2025.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 52.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 73.31 |
| PB Ratio | 21.08 |
| P/TBV Ratio | 21.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -101.83 |
| EV / Sales | 60.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -52.58 |
Financial Position
The company has a current ratio of 5.75, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.75 |
| Quick Ratio | 5.65 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.16 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.24% and return on invested capital (ROIC) is -14.35%.
| Return on Equity (ROE) | -18.24% |
| Return on Assets (ROA) | -12.49% |
| Return on Invested Capital (ROIC) | -14.35% |
| Return on Capital Employed (ROCE) | -24.53% |
| Revenue Per Employee | 217,321 |
| Profits Per Employee | -149,534 |
| Employee Count | 107 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.33% in the last 52 weeks. The beta is -0.67, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.67 |
| 52-Week Price Change | +13.33% |
| 50-Day Moving Average | 20.01 |
| 200-Day Moving Average | 17.77 |
| Relative Strength Index (RSI) | 56.10 |
| Average Volume (20 Days) | 153 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of 23.25 million and -16.00 million in losses. Loss per share was -0.18.
| Revenue | 23.25M |
| Gross Profit | 20.82M |
| Operating Income | -20.75M |
| Pretax Income | -17.12M |
| Net Income | -16.00M |
| EBITDA | -19.08M |
| EBIT | -20.75M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 70.38 million in cash and 4.90 million in debt, giving a net cash position of 65.48 million.
| Cash & Cash Equivalents | 70.38M |
| Total Debt | 4.90M |
| Net Cash | 65.48M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 80.86M |
| Book Value Per Share | 0.91 |
| Working Capital | 75.45M |
Cash Flow
In the last 12 months, operating cash flow was -28.58 million and capital expenditures -2.41 million, giving a free cash flow of -30.99 million.
| Operating Cash Flow | -28.58M |
| Capital Expenditures | -2.41M |
| Free Cash Flow | -30.99M |
| FCF Per Share | n/a |
Margins
Gross margin is 89.51%, with operating and profit margins of -89.22% and -68.81%.
| Gross Margin | 89.51% |
| Operating Margin | -89.22% |
| Pretax Margin | -73.64% |
| Profit Margin | -68.81% |
| EBITDA Margin | -82.06% |
| EBIT Margin | -89.22% |
| FCF Margin | n/a |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | -0.94% |
| FCF Yield | -1.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioArctic AB has an Altman Z-Score of 49.41.
| Altman Z-Score | 49.41 |
| Piotroski F-Score | n/a |